| STATE-OF-THE-ART REVIEW |
|
| Year : 2013 | Volume
: 6
| Issue : 2 | Page : 129-132 |
|
|
Focal ablation of prostate cancer
Georg Schatzl
Department of Urology, Medical University Vienna, Vienna, , and Karl Landsteiner Institute of Andrology and Prostate Research, Vienna, Austria
Correspondence Address:
Georg Schatzl
Department of Urology, Medical University Vienna, Waehringer Guertel 18–20, 1090 Vienna
Austria
 Source of Support: None, Conflict of Interest: None
DOI: 10.7707/hmj.v6i2.280
|
|
|
The aim of the article was to evaluate the treatment potential for focal therapies of prostate cancer (PCa). A literature research was performed to evaluate efficiency of the minimally invasive methods of PCa treatment. The two treatment methods evaluated were high-intensity focused ultrasonography (HIFU) and cryoablation. There are few studies with sufficient long-term follow-up and follow-up criteria are very diverse. The increasing number of cryoablation and HIFU treatments in the last 10 years confirms the considerable demand for minimally invasive treatment for localized PCa. Focal ablation of PCa is an interesting treatment option for low-risk PCa, but there are not many opportunities for this treatment and the patient experience is often negative.
|
|
|
|
| [PDF]* |
|
 |
|
